Does Anthem Blue Cross Cover Dexcom G6? Eligibility, Costs, and Denials

Anthem Blue Cross does cover the Dexcom G6 continuous glucose monitor when a doctor documents that it is medically necessary. In practice, that means you have diabetes, you use insulin multiple times a day or wear an insulin pump, and you have at least one additional clinical reason for continuous monitoring. Coverage runs through commercial plans, Medicare Advantage, and Medi-Cal managed care, though the paperwork, the ordering channel, and your out-of-pocket costs shift depending on which plan you hold.

One thing to know up front: Dexcom will stop manufacturing the G6 after July 1, 2026, and is steering current and new users toward the G7. Anthem’s coverage policy already lists both devices, so most of what follows applies to either one.1Dexcom. G6 Transition2Anthem. CG-DME-42 Continuous Glucose Monitoring Devices

Who Qualifies Under Anthem’s Policy

Anthem’s clinical utilization guideline for continuous glucose monitors, CG-DME-42, was last revised in April 2025. It applies to patients with any type of diabetes, but insulin use is a firm requirement.2Anthem. CG-DME-42 Continuous Glucose Monitoring Devices

To be approved, you must meet all three of these baseline conditions:

  • A diagnosis of diabetes mellitus of any type.
  • Multiple daily insulin injections or use of an insulin pump.
  • Demonstrated engagement with your treatment: you or your caregiver understand how the device works, can respond to alerts, and participate actively in a diabetes care plan.

On top of those baselines, you also need at least one of the following clinical indicators despite ongoing diabetes management:

  • HbA1c above target.
  • Persistent fasting hyperglycemia.
  • Recurring hypoglycemia with blood glucose below 54 mg/dL.
  • Hypoglycemia unawareness, meaning you cannot reliably sense low blood sugar.
  • For children or adolescents with type 1 diabetes, an HbA1c already below 7.0% that the device is needed to maintain while limiting hypoglycemia risk.

Coverage continues only if your records show the device is actually helping, through improved or stable HbA1c or fewer dangerous highs and lows.2Anthem. CG-DME-42 Continuous Glucose Monitoring Devices

Type 2 Diabetes Without Insulin

Type 2 patients are covered, but only if they take insulin several times a day or use a pump. Anthem’s guideline notes that evidence for CGM use among type 2 patients who do not use insulin is “less strong,” and as of the April 2025 revision the insurer has not extended coverage to that group.2Anthem. CG-DME-42 Continuous Glucose Monitoring Devices

If you have type 2 diabetes or pre-diabetes and don’t use insulin, Dexcom sells the Stelo Glucose Biosensor over the counter without a prescription. Anthem does not cover it, because the CGM policy specifically excludes devices approved for non-prescription use. Stelo retails at about $99 for two sensors and can be paid for with FSA or HSA funds.3Association of Diabetes Care and Education Specialists. Dexcom G7 and Stelo Differences

Pharmacy Benefit or Medical Benefit

How you order and pay for G6 supplies depends on which side of your plan handles continuous glucose monitors. Some Anthem plans route CGMs through the pharmacy benefit; others treat them as durable medical equipment under the medical benefit. Both still exist, and the difference changes who you call and what you pay.

If your CGM is a pharmacy benefit, claims run through CarelonRx, Anthem’s pharmacy benefit manager, and you pick up supplies at a pharmacy. If it is a medical benefit, you order through an authorized DME supplier such as Byram Healthcare, Edgepark Medical Supplies, Medtronic Diabetes, or Tandem Diabetes Care.4Anthem. Diabetic Supplies Anthem has said members generally receive supplies faster through the pharmacy route.5Anthem Provider News. Change in Coverage for Continuous Glucose Monitors for Some Fully Insured Groups Check your member materials or call the number on your card to confirm which channel applies to you.

What You’ll Pay

Out-of-pocket costs depend heavily on the plan. Colorado Option plans, for instance, cover diabetic supplies including Dexcom G6 products at zero cost-sharing, with no deductible, copay, or coinsurance.4Anthem. Diabetic Supplies For other plans, your Prescription Drug List or benefits summary will show the tier and copay.

Dexcom reports that most commercially insured patients with CGM coverage pay $20 or less per month for supplies.6Dexcom. Cost and Coverage If your share is higher or you have no coverage, Dexcom runs a pharmacy savings program that takes more than $200 off the retail price of a 30-day sensor supply. The coupon can be used up to 12 times a year at participating pharmacies but cannot be stacked with insurance.7Dexcom. Savings Center

Prior Authorization and Paperwork

Many Anthem plans require prior authorization. The clinical guideline does not use that phrase outright, but it sets out detailed medical necessity criteria that have to be documented before the plan will pay. In practice, your prescriber submits the clinical evidence.

What the provider usually needs to pull together:

  • Your diabetes diagnosis with the appropriate ICD-10 code; common ones include E10.65, E10.9, and E11.9.8CU Anschutz Medical Campus. Dexcom Order Form
  • Your insulin regimen, showing three or more injections a day or pump use.
  • Your self-monitoring history; some plans want evidence of fingersticks four or more times a day.
  • The qualifying clinical reason: elevated HbA1c, recurrent hypoglycemia, hypoglycemia unawareness, or another indicator from the policy.
  • A recent clinical visit. Medicare, for example, requires an in-person or telehealth evaluation with the treating provider within the six months before the CGM is ordered.9Medicare.gov. Continuous Glucose Monitors

For pharmacy benefit requests, the provider can call CarelonRx at 833-293-0659 or submit through CoverMyMeds. Medical benefit requests go through the Anthem provider portal.

Medicare Advantage

If you have an Anthem Medicare Advantage plan, Dexcom has been listed as a preferred CGM brand alongside FreeStyle Libre on most Medicare Advantage Part D plans since June 1, 2025. The plans cap Dexcom supplies at three sensors per 30 days, one transmitter per 90 days, and two receivers per 720 days.10Anthem Provider News. Medicare Preferred Continuous Glucose Monitors

Under traditional Medicare Part B, you qualify with a diabetes diagnosis plus either insulin use or a documented history of problematic hypoglycemia. You typically pay 20% of the approved amount after your Part B deductible, with secondary insurance often picking up the rest. Medicare also requires that you use a Dexcom receiver rather than relying solely on the smartphone app.11Dexcom. Medicare FAQs

Medi-Cal Managed Care

For Anthem Blue Cross Medi-Cal members in California, CGMs are a “partial carved-out medical supply,” which gives Anthem discretion over its own coverage criteria and reimbursement rates. The CG-DME-42 clinical criteria still apply, but the published Medi-Cal Rx covered device list does not explicitly name the Dexcom G6, so call Anthem directly to confirm your specific device is covered under your plan.12Anthem. Glucose Monitors – Medi-Cal

If Anthem Denies You

A denial is not the end. In California, you have 180 calendar days from the date on the denial letter to file an internal appeal by phone, mail, or through the member portal. Anthem has to acknowledge the filing within five calendar days and issue a written decision within 30 calendar days.13Anthem. Complaints and Grievances

If delay could jeopardize your health, you can request an expedited review and a physician will decide within 72 hours. If the internal appeal fails, you can take it to an Independent Medical Review through the California Department of Managed Health Care or the California Department of Insurance, which is especially useful for denials based on medical necessity or an experimental/investigational finding.

Patient advocacy groups report that more than half of insurance appeals ultimately succeed, so it is usually worth pursuing. A letter of support from the prescribing provider, attached to clinical records, lab results, and the relevant medical guidelines, strengthens the case.14Breakthrough T1D. Insurance Denials and Appeals

The G6 Is Being Phased Out

Before you commit to the G6, know that Dexcom will stop making it after July 1, 2026, and is asking current users to transition to the G7 or the newer G7 15 Day system. Supplies may stay on pharmacy and distributor shelves for a while afterward, but Dexcom cannot guarantee continued availability.1Dexcom. G6 Transition

For coverage, Dexcom says patients who have G6 coverage will have G7 coverage, and commercial coverage for the G7 15 Day sensor is expected to reach parity with the G6 shortly after launch. All Medicare patients who use insulin or have a history of severe hypoglycemia already have G7 coverage. If you use the G6 with an insulin pump, confirm your pump works with the G7 before switching; Dexcom recommends staying on the G6 until integration with your specific pump or pen system is confirmed.11Dexcom. Medicare FAQs

To check your own coverage for any Dexcom device, you can run a free benefits check on Dexcom’s website or call 1-866-448-0097.1Dexcom. G6 Transition